(R)-TRIP, (11bR)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]dinaphtho[2,1-d:1μ,2μ-f]-1,3,2-dioxaphosphepin 4-oxide, (R)-3,3μ-Bis(2,4,6-triisopropylphenyl)-1,1μ-bi-2-naphthol cyclic monophosphate

Synonym(s):(11bR)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]dinaphtho[2,1-d:1′,2′-f]-1,3,2-dioxaphosphepin 4-oxide;(11bS)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]dinaphtho[2,1-d:1′,2′-f]-1,3,2-dioxaphosphepin 4-oxide;(R)-3,3′-Bis(2,4,6-triisopropylphenyl)-1,1′-bi-2-naphthol cyclic monophosphate;(R)-TRIP;(S)-3,3′-Bis(2,4,6-triisopropylphenyl)-1,1′-bi-2-naphthol cyclic monophosphate

CAS NO.：791616-63-2
Empirical Formula: C50H57O4P
Molecular Weight: 752.98
MDL number: MFCD10567009
SAFETY DATA SHEET (SDS)
Update Date: 2026-01-13 11:21:02

(R)-TRIP, (11bR)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]dinaphtho[2,1-d:1μ,2μ-f]-1,3,2-dioxaphosphepin 4-oxide, (R)-3,3μ-Bis(2,4,6-triisopropylphenyl)-1,1μ-bi-2-naphthol cyclic monophosphate Structural

What is (R)-TRIP, (11bR)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]dinaphtho[2,1-d:1μ,2μ-f]-1,3,2-dioxaphosphepin 4-oxide, (R)-3,3μ-Bis(2,4,6-triisopropylphenyl)-1,1μ-bi-2-naphthol cyclic monophosphate?

The Uses of (R)-TRIP, (11bR)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]dinaphtho[2,1-d:1μ,2μ-f]-1,3,2-dioxaphosphepin 4-oxide, (R)-3,3μ-Bis(2,4,6-triisopropylphenyl)-1,1μ-bi-2-naphthol cyclic monophosphate

Versatile organocatalyst. Uses include asymmetric reductive amination, enantioselective Diels-Alder reactions and asymmetric counteranion-directed catalysis (ACDC). Can be used in cooperation with chiral iridium complexes to catalyze greener asymmetric reductive amination using hydrogen gas.

Metal-Br?nsted Acid Cooperative Catalysis for Asymmetric Reductive Amination

What are the applications of Application

(R)-TRIP is a chiral phosphonic acid ligand

Definition

ChEBI: (S)-TRIP is a member of benzenes, a ring assembly and a member of naphthalenes.

General Description

This product has been enhanced for catalytic efficiency.

Properties of (R)-TRIP, (11bR)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]dinaphtho[2,1-d:1μ,2μ-f]-1,3,2-dioxaphosphepin 4-oxide, (R)-3,3μ-Bis(2,4,6-triisopropylphenyl)-1,1μ-bi-2-naphthol cyclic monophosphate

Boiling point:	814.2±75.0 °C(Predicted)
Density	1.17±0.1 g/cm3(Predicted)
storage temp.	Inert atmosphere,Room Temperature
pka	1.12±0.20(Predicted)
form	Powder
color	white to light-yellow

Safety information for (R)-TRIP, (11bR)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]dinaphtho[2,1-d:1μ,2μ-f]-1,3,2-dioxaphosphepin 4-oxide, (R)-3,3μ-Bis(2,4,6-triisopropylphenyl)-1,1μ-bi-2-naphthol cyclic monophosphate

Signal word	Danger
Pictogram(s)	Exclamation Mark Irritant GHS07
GHS Hazard Statements	H315:Skin corrosion/irritation H319:Serious eye damage/eye irritation H335:Specific target organ toxicity, single exposure;Respiratory tract irritation
Precautionary Statement Codes	P261:Avoid breathing dust/fume/gas/mist/vapours/spray. P280:Wear protective gloves/protective clothing/eye protection/face protection. P304+P340:IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. P405:Store locked up.

Computed Descriptors for (R)-TRIP, (11bR)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]dinaphtho[2,1-d:1μ,2μ-f]-1,3,2-dioxaphosphepin 4-oxide, (R)-3,3μ-Bis(2,4,6-triisopropylphenyl)-1,1μ-bi-2-naphthol cyclic monophosphate

InChIKey

AGQAQYPGJDBIQR-UHFFFAOYSA-N

New Products

4-Iodo-3,5-dimethylbenzonitrile 2-fluoro-4-iodoaniline 2-(3-Methyl-1,2,4-oxadiazol-5-yl)acetic acid (as potassium salt) 6,6'-methylenebis(9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-2,3-dihydro-1H-carbazol-4(9H)-one) 3-Bromo-2-fluorobenzoic acid Quinuclidine-4-carbonitrile N,N CARBONYL DIIMIDAZOLE 2-Amino-5-bromo-4-(trifluoromethyl)pyridine（RM for Indian lab) (RS)-beta-Amino-beta-(4-bromophenyl)propionic acid Tetrabutylammonium perchlorate N,O-Dimethylhydroxylamine hydrochloride (R)-1-Benzyl-3-pyrrolidinecarbonitrile Bupropian related compound F Lantanoprost rc B Clidinium Bromide Impurity Noradrenaline EP Impurity D/Noradrenaline Methyl Ether Cetirizine EP Impurity A/Cetirizine CBHP Impurity N-Nitroso hydroxy Cetrizine EP Impurity-A 4-(5-amino-1-methyl-1h-benzoimidazol-2-yl)-butyric acid isopropyl ester. 1,4-bis(methylsulfonyl)butane 4-Cyano-N-Methacryloyl-3-Trifluoromethyl Aniline 5-Methyl-1,3-benzenediacetonitrile 4-Fluorothiophenol 1-methyl amino-2,4-dinitro benzene

Related products of tetrahydrofuran

(S)-TRIP, (11bS)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]dinaphtho[2,1-d:1μ,2μ-f]-1,3,2-dioxaphosphepin 4-oxide, (S)-3,3μ-Bis(2,4,6-triisopropylphenyl)-1,1μ-bi-2-naphthol cyclic monophosphate

(11bR)-2,6-Di-9-phenanthrenyl-4-hydroxy-dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-oxide

R-4-oxide-4-hydroxy-2,6-di-2-naphthalenyl-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

R-3,3'-Bis(phenyl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate

S-3,3'-Bis(phenyl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate

Ir(I)/(S)-t-Bu-PHOX

R-4-oxide-4-hydroxy-2,6-bis(4-Methoxyphenyl)-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

(11bS)-2,6-Di-9-phenanthrenyl-4-hydroxy-dinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin-4-oxide